NeuroScientific Biopharmaceuticals Limited (ASX:NSB)

ASX:NSB Balance Sheet

Financials in millions AUD. Fiscal year is July - June.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Cash & Equivalents	1.11	7.27	4.95	4.91	7.22	14.16
Cash & Short-Term Investments	6.36	7.27	4.95	4.91	7.22	14.16
Cash Growth	41.48%	46.66%	0.86%	-31.93%	-49.05%	330.88%
Accounts Receivable	0.12	0.1	0.05	0.04	0.12	0.05
Receivables	0.12	0.1	0.05	0.04	0.12	0.05
Prepaid Expenses	0.1	0.03	0.04	0.05	0.06	0.22
Total Current Assets	6.57	7.4	5.04	5.01	7.4	14.43
Property, Plant & Equipment	0	0	0.01	0.01	0.02	0.03
Other Intangible Assets	10.09	9.57	0.39	0.27	0.32	0.37
Total Assets	16.66	16.96	5.44	5.29	7.74	14.83
Accounts Payable	0.19	0.15	0.08	0.59	2.17	0.18
Accrued Expenses	0.02	-	0	0.01	0.05	0.05
Total Current Liabilities	0.21	0.15	0.09	0.6	2.22	0.22
Total Liabilities	0.21	0.15	0.09	0.6	2.22	0.22
Common Stock	34.26	34.26	25.52	25.27	25.27	25.27
Retained Earnings	-24.98	-23.28	-22.04	-22.99	-22.6	-12.18
Comprehensive Income & Other	7.18	5.84	1.87	2.41	2.84	1.5
Shareholders' Equity	16.45	16.81	5.35	4.69	5.52	14.6
Total Liabilities & Equity	16.66	16.96	5.44	5.29	7.74	14.83
Net Cash (Debt)	6.36	7.27	4.95	4.91	7.22	14.16
Net Cash Growth	41.48%	46.66%	0.86%	-31.93%	-49.05%	330.88%
Net Cash Per Share	0.03	0.05	0.03	0.03	0.05	0.10
Filing Date Shares Outstanding	332.58	332.58	144.6	143.47	143.47	143.47
Total Common Shares Outstanding	332.58	332.58	144.6	143.47	143.47	143.47
Working Capital	6.37	7.25	4.96	4.41	5.18	14.2
Book Value Per Share	0.05	0.05	0.04	0.03	0.04	0.10
Tangible Book Value	6.37	7.25	4.96	4.42	5.2	14.23
Tangible Book Value Per Share	0.02	0.02	0.03	0.03	0.04	0.10

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.